Johns Hopkins/NCI Molecular Target and Drug Discovery Fellowship
Meet Chris Larrimore, current MS in Biotechnology student and NCI fellow. Learn more at http://biotechnology.jhu.edu
The Johns Hopkins University and the Center for Cancer Research/National Cancer Institute (CCR/NCI) have partnered to create a new concentration in the Master of Science in Biotechnology program, called Molecular Targets and Drug Discovery Technologies. This innovative program will focus on bioassay development, chemical libraries, molecular targets and cancer, and high throughput screening laboratory automation.
A special feature of the concentration is the CCR/NCI Fellowship Program. This competitive program will recruit immediate post-baccalaureates to work in CCR/NCI laboratories on projects related to the Molecular Targets Initiative.
While studying for the Master of Science in Biotechnology, the fellows will receive paid tuition for up to two years and an annual stipend. Ten Courses will be required for graduation (4 core courses, 6 electives). Practical lab courses are included as part of the curriculum.
Core Science Courses (4 courses required):
- Molecular Biology
- Advanced Cellular Biology I
- Advanced Cellular Biology II
Core Molecular Targets and Drug Discovery Technologies Courses (4 courses required):
- Molecular Targets and Cancer
- Bioassay Development
- Chemical Libraries and Diversity
- High-Throughput Screening and Automation Laboratory
Electives (2 courses selected):
- Molecular Basis of Pharmacology
- Introduction to Bioinformatics
- Protein Bioinformatics
- Cell Culture Techniques
- Microarray and Analysis
- Microfluids and Biosensors
CCR contact:Jonathan S. Wiest, Ph.D.
Associate Director for Training and Education
Office of Training and Education
CCR Office of the Director
National Cancer Institute
Building 31 Room 4A48
31 Center Drive
Bethesda, MD. 20852